Clinical Trials Logo

Clinical Trial Summary

The primary objective of this randomized, double-blind, placebo-controlled, cross-over study is to assess the acute effects of a novel ingredient, guayusa on alertness and mental fatigue compared to a placebo. This trial will utilize the COMPASS cognitive task and cognitive demand battery (CDB) and mood, motivation, and energy measures with assessments taking place at baseline, 60- and 120-minutes post treatment on three separate testing days separated by ~7 days.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05530915
Study type Interventional
Source PepsiCo Global R&D
Contact
Status Completed
Phase N/A
Start date July 27, 2022
Completion date November 7, 2022